Investors, patients await FDA decision on Biogen Alzheimer's drug due Monday
Go back to Investors, patients await FDA decision on Biogen Alzheimer's drug due Monday| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 223.99 +1.32 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $222.67 | 52 Week High | $333.65 | |||
| Open | $225.44 | 52 Week Low | $223.02 | |||
| Day High | $225.80 | P/E | 28.68 | |||
| Day Low | $221.23 | EPS | $7.81 | |||
| Volume | 212,739 | |||||
